Defensive responses to the U.S. Surgeon General’s alcohol-cancer advisory: A topic modeling analysis of TikTok comments

• by Zexin Ma, Christian Otchere, Xinyan Zhao

• October 14, 2026

Musings From the Power List: Jason Bock

Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development

• by Jason Bock

• October 14, 2026

• 14 min

Spinal ependymoma: a comprehensive review of molecular classification, management guidelines, and clinical outcomes with a focus on the pediatric population (Part III of ependymomas across compartments)

• by Anthony M. Price, Nathan S. Fredricks, George Koutsouras, Frederic A. Vallejo, Christopher Bonfield, Devang J. Pastakia, Leo Y. Luo, Frederick Boop, Vijay Ramaswamy, Michael C. Dewan

• October 6, 2026

GLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History

• by Olinto Linares-Perdomo, Damon Klebe, Fumiko Chino, Bismarck C. Odei

• October 7, 2026